PTYXO
LIVE

Serial Number

79217979

Owner

NOVARTIS AG

Filing Date

Jul 28, 2017

Add to watchlist:

No watchlists yet
View on USPTO

PTYXO Trademark

Serial Number: 79217979 • Registration: 5409780

PTYXO is a trademark filed by NOVARTIS AG on July 28, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

July 28, 2017

Registration Date

February 27, 2018

Published for Opposition

December 12, 2017

Cancellation Date

September 13, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Sep 27, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 9, 2025 INTS
INVALIDATION PROCESSED
Sep 9, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 13, 2025 INTR
CANCELLED SECTION 71
Sep 13, 2024 C71T
INTERNATIONAL REGISTRATION RENEWED
Oct 12, 2023 RNWL
NOTIFICATION PROCESSED BY IB
Apr 19, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Apr 3, 2018 FICS
FINAL DISPOSITION PROCESSED
Apr 3, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Mar 29, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Feb 27, 2018 R.PR
PUBLISHED FOR OPPOSITION
Dec 12, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Dec 8, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 22, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 22, 2017 OP2R
NOTICE OF PUBLICATION
Nov 22, 2017 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2017 CNSA
ASSIGNED TO EXAMINER
Oct 28, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 17, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 12, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 6, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Oct 5, 2017 SDRC